• OPEN AN ACCOUNT
Indian Indices
Sensex
76,944.28 -12.99
( -0.02%)
Global Indices
Nasdaq
53,227.35 -353.64
(-0.66%)
Dow Jones
7,711.10 -21.66
(-0.28%)
Hang Seng
66,431.13 119.20
(0.18%)
Nikkei 225
10,792.77 -31.49
(-0.29%)
Forex
USD-INR
95.47 -0.01
(-0.01%)
EUR-INR
110.57 -0.67
(-0.60%)
GBP-INR
129.19 -0.55
(-0.42%)
JPY-INR
0.60 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Reliance Industries Ltd
Industry :  Refineries
BSE Code
ISIN Demat
Book Value()
500325
INE002A01018
418.4253247
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
RELIANCE
44.34
1738930.75
EPS(TTM)
Face Value()
Div & Yield %
28.98
10
0.47
 

InvaGen receives EIR report for its facility in Hauppauge, New York
Aug 04,2026
Cipla announced that its wholly owned subsidiary, InvaGen Pharmaceuticals (InvaGen) has received the Establishment Inspection Report (EIR) from the USFDA, indicating the closure of the inspection of its manufacturing facility located at Hauppauge, Long Island, New York, USA.